Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
MiMedx Group, Inc.

MiMedx Group, Inc. (MDXG) Stock Overview

Explore MiMedx Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.

MDXG●NASDAQ
HealthcareBiotechnology
$4.71
$0.08(1.62%)
U.S. Market is Open · 10:25

MiMedx Group, Inc. (MDXG)

Meyka AI Score

Z

Key Financials

Market Cap688M
P/E Ratio119.13
EPS (TTM)$0.34
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$4.47
3 Months$5.30
1 Year Target$3.59

MDXG Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of MiMedx Group, Inc. (NASDAQ: MDXG) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, MiMedx Group, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MDXG on the NASDAQ shows an RSI of 65.81, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.59 for the NASDAQ listing.

Key metrics behind MiMedx Group, Inc.'s NASDAQ-traded stock include a P/E ratio of 119.13 and a market capitalization of 688M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MDXG on the NASDAQ.

Price Performance (NASDAQ: MDXG)

1-Day Change
1.72%
5-Day Change
1.51%
1-Month Change
10.54%
3-Month Change
28.26%
6-Month Change
7.76%
Year-to-Date (YTD) Change
-30.28%
1-Year Change
-32.28%
3-Year Change
-37.40%
5-Year Change
-15.56%
All-Time (Max) Change
1.72%

Contact Information

https://www.mimedx.com
770 651 9100
1775 West Oak Commons Court, NE, Marietta, GA, 30062

Company Facts

8,080 Employees
IPO DateFeb 12, 2008
CountryUS
Actively Trading

Frequently Asked Questions